Here's a recap of blog posts and other news from the past month.
We hope you like them. If you do, please share them.
Also published this month is
Study 329 Continuation Phase
. This was a six month extension phase of Study 329 that has remained unpublished for 18 years. It's not hard to spot why GSK chose not to publish.
Thank you for your support.
Your feedback, as always, is greatly appreciated.
David Healy, MD